Oxycodon Painbreak Pb Pharma (Oxycodone Hydrochloride Ph. Eur.)

Oxycodone Hydrochloride, the active ingredient in Oxycodon Painbreak Pb Pharma, is an opioid analgesic presented as a 10 mg tablet for oral use. It is employed in the management of moderate to severe pain, typically in adult patients when other analgesics are insufficient.

GNH USA supplies Oxycodon Painbreak Pb Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Hydrochloride is an opioid analgesic that acts on the central nervous system to relieve pain. - Acute postoperative pain: provides strong analgesia during the recovery period after surgery. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: reduces pain intensity when other treatments have failed.

Adverse reactions may range from mild to life‑threatening and should be monitored during therapy.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea and vomiting: upset stomach and emesis. - Drowsiness or sedation: increased sleepiness. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivary flow. - Pruritus: mild itching.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Opioid use disorder: dependence or addiction. - Seizures: rare convulsive episodes. - Anaphylaxis: acute allergic reaction with airway compromise. - Adrenal insufficiency: impaired cortisol production.

Before initiating therapy, clinicians should evaluate patient history and monitor for potential complications. - Assess renal and hepatic function: adjust dosing if impairment is present. - Evaluate for respiratory disorders: avoid use in severe asthma or COPD. - Review concomitant CNS depressants: increased sedation risk. - Counsel on constipation management: use laxatives or stool softeners as needed. - Monitor for signs of dependence: educate patients on proper use. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxycodone may interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: combined CNS depression can cause profound sedation or respiratory failure. - MAO inhibitors: risk of severe hypertension or serotonin syndrome. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increase oxy‑hydroxy‑oxycodone levels, heightening toxicity.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may reduce conversion to active metabolites, altering analgesia. - CNS depressants (e.g., antihistamines, muscle relaxants): additive sedative effects. - Diuretics: may exacerbate hypotension. - Anticholinergics: increase risk of urinary retention and constipation.